J.M. Morales

5.9k total citations
154 papers, 3.9k citations indexed

About

J.M. Morales is a scholar working on Transplantation, Surgery and Psychiatry and Mental health. According to data from OpenAlex, J.M. Morales has authored 154 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 97 papers in Transplantation, 54 papers in Surgery and 36 papers in Psychiatry and Mental health. Recurrent topics in J.M. Morales's work include Renal Transplantation Outcomes and Treatments (97 papers), Organ Transplantation Techniques and Outcomes (40 papers) and Neurological Complications and Syndromes (33 papers). J.M. Morales is often cited by papers focused on Renal Transplantation Outcomes and Treatments (97 papers), Organ Transplantation Techniques and Outcomes (40 papers) and Neurological Complications and Syndromes (33 papers). J.M. Morales collaborates with scholars based in Spain, United States and France. J.M. Morales's co-authors include Josep M. Campistol, Amado Andrés, José L. Rodicio, Manuel Praga, Beatriz Domínguez‐Gil, Estela Paz‐Artal, Henri Kreis, Luís M. Ruilope, James T. Burke and Kerstin Claesson and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and Annals of Internal Medicine.

In The Last Decade

J.M. Morales

151 papers receiving 3.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J.M. Morales Spain	35	2.0k	1.1k	892	773	511	154	3.9k
Joshua Miller United States	39	2.7k 1.4×	2.0k 1.7×	749 0.8×	649 0.8×	508 1.0×	131	4.7k
Paolo Rigotti Italy	38	2.5k 1.3×	2.0k 1.7×	702 0.8×	441 0.6×	1.1k 2.1×	199	4.8k
Winfred W. Williams United States	27	2.5k 1.2×	1.5k 1.3×	533 0.6×	507 0.7×	478 0.9×	64	4.0k
Douglas J. Norman United States	36	1.8k 0.9×	1.3k 1.1×	924 1.0×	220 0.3×	555 1.1×	124	4.0k
Velma P. Scantlebury United States	37	2.2k 1.1×	1.8k 1.5×	636 0.7×	561 0.7×	849 1.7×	137	4.4k
H Wilczek Sweden	32	1.2k 0.6×	1.1k 0.9×	729 0.8×	338 0.4×	322 0.6×	88	3.1k
Mark L. Jordan United States	35	2.2k 1.1×	1.6k 1.4×	513 0.6×	276 0.4×	723 1.4×	173	4.3k
K. Salmela Finland	41	1.9k 0.9×	3.2k 2.7×	866 1.0×	304 0.4×	662 1.3×	189	5.6k
B Charpentier France	30	1.8k 0.9×	1.1k 1.0×	709 0.8×	199 0.3×	638 1.2×	204	3.8k
Barbara A. Bresnahan United States	19	3.0k 1.5×	1.8k 1.6×	581 0.7×	235 0.3×	933 1.8×	36	4.3k

Countries citing papers authored by J.M. Morales

Since Specialization

Citations

This map shows the geographic impact of J.M. Morales's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.M. Morales with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.M. Morales more than expected).

Fields of papers citing papers by J.M. Morales

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.M. Morales. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.M. Morales. The network helps show where J.M. Morales may publish in the future.

Co-authorship network of co-authors of J.M. Morales

This figure shows the co-authorship network connecting the top 25 collaborators of J.M. Morales. A scholar is included among the top collaborators of J.M. Morales based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.M. Morales. J.M. Morales is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Morales, J.M., et al.. (2024). INTERGENERATIONAL WORKSHOP TO EMPOWER OLDER ADULTS IN SMART TECHNOLOGIES. Innovation in Aging. 8(Supplement_1). 502–503. 1 indexed citations

Cabrera-Marante, Óscar, Manuel Serrano, José A. Martínez-Flores, et al.. (2017). Incidence of thromboembolic events in asymptomatic carriers of IgA anti ß2 glycoprotein-I antibodies. PLoS ONE. 12(7). e0178889–e0178889. 33 indexed citations

Martínez-Flores, José A., Manuel Serrano, J.M. Morales, & Antonio Serrano. (2016). Antiphospholipid Syndrome and Kidney Involvement: New Insights. Antibodies. 5(3). 17–17. 4 indexed citations

Serrano, Manuel, Óscar Cabrera-Marante, José A. Martínez-Flores, et al.. (2016). Study of β2–Glycoprotein I Polymorphisms in Patients With Chronic Renal Failure as a Predisposing Factor for the Development of Anti–β2–Glycoprotein I Auto-Antibodies. Transplantation Proceedings. 48(9). 2876–2879. 1 indexed citations

Cruzado, Josep M., Julio Pascual, Ana Sánchez‐Fructuoso, et al.. (2016). Controlled randomized study comparing the cardiovascular profile of everolimus with tacrolimus in renal transplantation. Transplant International. 29(12). 1317–1328. 15 indexed citations

Serrano, Manuel, José A. Martínez-Flores, María José Castro, et al.. (2014). Renal Transplantation Dramatically Reduces IgA Anti-beta-2-glycoprotein I Antibodies in Patients with Endstage Renal Disease. Journal of Immunology Research. 2014. 1–10. 20 indexed citations

Serrano, Antonio, Manuel Serrano, David Lora, et al.. (2012). IgA antibodies against β2 glycoprotein I in hemodialysis patients are an independent risk factor for mortality. Kidney International. 81(12). 1239–1244. 49 indexed citations

Medina‐Polo, José, J.M. Morales, Amado Andrés, et al.. (2010). Cardiovascular Events After Simultaneous Pancreas-Kidney Transplantation. Transplantation Proceedings. 42(8). 2981–2983. 10 indexed citations

Morales, J.M., Anders Hartmann, Rowan G. Walker, et al.. (2009). Similar Lipid Profile But Improved Long-Term Outcomes With Sirolimus After Cyclosporine Withdrawal Compared to Sirolimus With Continuous Cyclosporine. Transplantation Proceedings. 41(6). 2339–2344. 2 indexed citations

10.

Morales, J.M., et al.. (2009). Frequency and Influence of Hemochromatosis Gene Mutations in Kidney Transplant Recipients With or Without Hepatitis C Virus Infection. Transplantation Proceedings. 41(6). 2422–2424. 2 indexed citations

11.

Jiménez‐Romero, Carlos, Alejandro Manrique, J.C. Meneu, et al.. (2009). Compative Study of Bladder Versus Enteric Drainage in Pancreas Transplantation. Transplantation Proceedings. 41(6). 2466–2468. 16 indexed citations

12.

Morales, J.M., Roberto Marcén, Amado Andrés, et al.. (2008). Renal transplantation in the modern immunosuppressive era in Spain: four-year results from a multicenter database focus on post-transplant cardiovascular disease. Kidney International. 74(111). S94–S99. 40 indexed citations

13.

Campistol, Josep M., Josette Eris, Rainer Oberbauer, et al.. (2006). Sirolimus Therapy after Early Cyclosporine Withdrawal Reduces the Risk for Cancer in Adult Renal Transplantation. Journal of the American Society of Nephrology. 17(2). 581–589. 373 indexed citations

14.

Morales, J.M.. (2004). Cardiovascular risk profile in patients treated with sirolimus after renal transplantation. Kidney International. 67(93). S69–S73. 17 indexed citations

15.

Ruiz, Juan Carlos, Josep M. Campistol, A. Mota, et al.. (2003). Early elimination of cyclosporine in kidney transplant recipients receiving sirolimus prevents progression of chronic pathologic allograft lesions. Transplantation Proceedings. 35(5). 1669–1670. 16 indexed citations

16.

Morales, J.M., Lars Wramner, Henri Kreis, et al.. (2002). Sirolimus Does Not Exhibit Nephrotoxicity Compared to Cyclosporine in Renal Transplant Recipients. American Journal of Transplantation. 2(5). 436–442. 163 indexed citations

17.

Squifflet, Jean-Paul, Kerstin Claesson, K.-H. Dietl, et al.. (2001). DOSE OPTIMIZATION OF MYCOPHENOLATE MOFETIL WHEN ADMINISTERED WITH A LOW DOSE OF TACROLIMUS IN CADAVERIC RENAL TRANSPLANT RECIPIENTS. Transplantation. 72(1). 63–69. 114 indexed citations

18.

Fernández‐Miranda, Consuelo, J.M. Morales, Carlos Guijarro, et al.. (1998). Lipoprotein abnormalities in long‐term stable liver and renal transplanted patients. A comparative study. Clinical Transplantation. 12(2). 136–141. 24 indexed citations

19.

Undre, Nasrullah, J van Hooff, Maarten H. L. Christiaans, et al.. (1998). Pharmacokinetics of FK 506 and Mycophenolic Acid After the Administration of a FK 506–Based Regimen in Combination With Mycophenolate Mofetil in Kidney Transplantation. Transplantation Proceedings. 30(4). 1299–1302. 36 indexed citations

20.

Rodicio, José L., J.M. Morales, José María Morillas Alcázar, & Luís M. Ruilope. (1993). Calcium antagonists and renal protection. Journal of Hypertension. 11(Supplement 1). S49–S53. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact